IL1B and obesity disorder: The inhibition of obesity-induced tumour growth and angiogenesis by metformin precisely phenocopied the blockade of IL-1 signalling, suggesting that metformin may act within this pathway, possibly by blocking IL-1β-mediated upregulation of Vegfa in adipocytes (Fig. 6f).